CA1238284A - Monoclonal antibody stabilization - Google Patents

Monoclonal antibody stabilization

Info

Publication number
CA1238284A
CA1238284A CA000486466A CA486466A CA1238284A CA 1238284 A CA1238284 A CA 1238284A CA 000486466 A CA000486466 A CA 000486466A CA 486466 A CA486466 A CA 486466A CA 1238284 A CA1238284 A CA 1238284A
Authority
CA
Canada
Prior art keywords
monoclonal antibody
day
ovalbumin
hydrolyzed
theophylline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000486466A
Other languages
English (en)
French (fr)
Inventor
Randall J. Avers
Robert H. Dodge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of CA1238284A publication Critical patent/CA1238284A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA000486466A 1984-08-09 1985-07-08 Monoclonal antibody stabilization Expired CA1238284A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US639,156 1984-08-09
US06/639,156 US4650772A (en) 1984-08-09 1984-08-09 Monoclonal antibody stabilization

Publications (1)

Publication Number Publication Date
CA1238284A true CA1238284A (en) 1988-06-21

Family

ID=24562959

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000486466A Expired CA1238284A (en) 1984-08-09 1985-07-08 Monoclonal antibody stabilization

Country Status (15)

Country Link
US (1) US4650772A (https=)
EP (1) EP0170983B1 (https=)
JP (1) JPH0699325B2 (https=)
KR (1) KR900002652B1 (https=)
AT (1) ATE57021T1 (https=)
AU (1) AU592952B2 (https=)
CA (1) CA1238284A (https=)
DE (1) DE3579868D1 (https=)
DK (1) DK333185A (https=)
ES (1) ES8702790A1 (https=)
GR (1) GR851926B (https=)
IE (1) IE58626B1 (https=)
IL (1) IL75762A (https=)
NZ (1) NZ212694A (https=)
ZA (1) ZA855248B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
DE3877015T2 (de) * 1987-02-20 1993-05-06 Akzo Nv Antikoerper enthaltende stabilisierte waesserige zusammensetzung.
US5237054A (en) * 1987-02-20 1993-08-17 Akzo Pharma Stabilized aqueous composition containing antibodies
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
JP2627681B2 (ja) * 1990-07-18 1997-07-09 同仁医薬化工株式会社 マイコプラズマ・ニューモニエ診断用試薬
WO1992001808A1 (fr) * 1990-07-18 1992-02-06 Dojin Iyaku-Kako Co., Ltd. Reactif permettant de diagnostiquer mycoplasma pneumoniae
JPH0565233A (ja) * 1991-03-08 1993-03-19 Mitsui Toatsu Chem Inc モノクローナル抗体含有凍結乾燥製剤
JP2553445B2 (ja) * 1992-12-17 1996-11-13 同仁医薬化工株式会社 抗体の安定化方法
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
AU2006247039B2 (en) * 2005-05-19 2011-03-03 Amgen Inc. Compositions and methods for increasing the stability of antibodies
WO2011093745A1 (en) * 2010-01-26 2011-08-04 Obschestvo S Ogranichennoi Otvetstvennostyu "Nauchno- Proizvodstvennaya Firma "Materia Medika Kholding" Method of determination of autoantibody level by means of enzyme immunoassay

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5816471B2 (ja) * 1977-11-29 1983-03-31 持田製薬株式会社 免疫化学的測定試薬の安定化剤
US4444880A (en) * 1982-07-27 1984-04-24 Syva Company Periodate removal of ascorbate interference in dipsticks for immunoassays
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin

Also Published As

Publication number Publication date
ATE57021T1 (de) 1990-10-15
EP0170983A3 (en) 1988-01-27
KR860001594A (ko) 1986-03-20
ES545975A0 (es) 1987-01-16
JPS6176423A (ja) 1986-04-18
US4650772A (en) 1987-03-17
IL75762A (en) 1989-10-31
GR851926B (https=) 1985-12-09
ZA855248B (en) 1986-02-26
IE58626B1 (en) 1993-10-20
DE3579868D1 (de) 1990-10-31
ES8702790A1 (es) 1987-01-16
EP0170983A2 (en) 1986-02-12
NZ212694A (en) 1988-05-30
KR900002652B1 (ko) 1990-04-21
EP0170983B1 (en) 1990-09-26
AU592952B2 (en) 1990-02-01
DK333185D0 (da) 1985-07-22
JPH0699325B2 (ja) 1994-12-07
IL75762A0 (en) 1985-11-29
DK333185A (da) 1986-02-10
AU4536985A (en) 1986-02-13
IE851964L (en) 1986-02-09

Similar Documents

Publication Publication Date Title
Cardenas et al. Bovine Pyruvate Kinases: I. PURIFICATION AND CHARACTERIZATION OF THE SKELETAL MUSCLE ISOZYME
CA1238284A (en) Monoclonal antibody stabilization
CA1092498A (en) Stabilizers for reconstituted, lyophilized samples
Inagaki et al. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
US3985867A (en) Immunoassays employing a colored second antibody
Kobayashi et al. Ca2+ regulated modulator protein interacting agents: Inhibition of Ca2+ Mg2+-ATPase of human erythrocyte ghost
Cummins et al. Myosin transitions in the bovine and human heart. A developmental and anatomical study of heavy and light chain subunits in the atrium and ventricle.
McCans et al. Antigenic differences in (Na+, K+)-ATPase preparations isolated from various organs and species.
CA1168580A (en) Immunological reagent for the detection of tubes of the rheumatoid factor in a biological specimen and process for preparing this novel reagent
JPS62118887A (ja) クレアチンキナーゼ用対照及び標準血清の製法及び該血清
CA1108048A (en) Sensitized erythrocytes stabilized with pyruvic aldehyde or dimethyl suberimidate
CA2156736C (en) Competitive immunoassay utilizing binding protein in a multiclonal antibody format
US4330620A (en) Method and reagent for the determination of creatine kinase MB
Honigberg et al. Immunologic analysis by quantitative fluorescent antibody methods of the effects of prolonged cultivation on Trichomonas gallinae
Harris et al. Effect of thermodynamic nonideality on the subcellular distribution of enzymes: adsorption of aldolase to muscle myofibrils
WO2000040973A1 (en) Assay for homocysteine
Sidorowicz et al. Multiple molecular forms of human alanine aminopeptidase: immunochemical properties
US4632907A (en) Preservative solution for fixed avian erythrocytes for the viral hemagglutination test
US5602234A (en) Stable antibody solution and method for preparing same
Grimaldi et al. Interaction of carbohydrate and protein in thyroxine binding globulin
Olwin et al. Immunoaffinity purification and characterization of 5-[[[(iodoacetyl) amino] ethyl] amino] naphthalene-1-sulfonic acid-derivatized calmodulin
CN101955539B (zh) 一种检测氯霉素的免疫试剂盒及其专用抗体
KR100342935B1 (ko) 효소표지항체를안정화시키는희석액
Kessler-Icekson et al. Ventricular myosin of the shrew Crocidura russula, correlation with contractile properties
Hayashi THE CHEMISTRY AND IMMUNOLOGY OF THE J-SUBSTANCE

Legal Events

Date Code Title Description
MKEX Expiry